基底细胞癌：使用检查点抑制剂治疗晚期或转移性癌症以及新的浅表肿瘤同时出现矛盾性进展。 - Suppr

Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors.

作者信息

Cohen Philip R, Kurzrock Razelle

机构信息

San Diego Family Dermatology, National City, California; Touro University California College of Osteopathic Medicine, Vallejo, California; Scripps Family Medicine Residency, Scripps Mercy Hospital Chula Vista, Chula Vista, California; Family Medicine Residency, Family Health Centers of San Diego, San Diego, California.

Department of Medicine, Division of Hematology/Oncology, University of California San Diego, La Jolla, California; Center of Personalized Cancer Therapy, University of California San Diego, La Jolla, California.

出版信息

J Am Acad Dermatol. 2020 Jun;82(6):e253-e254. doi: 10.1016/j.jaad.2020.02.052. Epub 2020 Feb 25.

DOI:10.1016/j.jaad.2020.02.052

PMID:32109540

Abstract

摘要

相似文献

Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors.基底细胞癌：使用检查点抑制剂治疗晚期或转移性癌症以及新的浅表肿瘤同时出现矛盾性进展。

J Am Acad Dermatol. 2020 Jun;82(6):e253-e254. doi: 10.1016/j.jaad.2020.02.052. Epub 2020 Feb 25.

Reply to Letter to the Editor regarding: "Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors".致编辑信件的回复，内容涉及：“基底细胞癌：使用检查点抑制剂治疗晚期或转移性癌症以及同时出现新的浅表肿瘤的矛盾性发展”

J Am Acad Dermatol. 2022 Mar;86(3):e107-e108. doi: 10.1016/j.jaad.2020.06.987. Epub 2020 Jun 27.

Immune checkpoint inhibitors for advanced or metastatic basal cell carcinoma: how much evidence do we need?免疫检查点抑制剂治疗晚期或转移性基底细胞癌：我们需要多少证据？

Immunotherapy. 2021 Oct;13(15):1293-1304. doi: 10.2217/imt-2021-0089. Epub 2021 Aug 31.

Use of PD-1 Inhibitors in the Treatment of Advanced Basal Cell Carcinoma.PD-1抑制剂在晚期基底细胞癌治疗中的应用。

Dermatol Surg. 2021 Nov 1;47(11):1511-1512. doi: 10.1097/DSS.0000000000003207.

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.西妥昔单抗治疗后局部晚期基底细胞癌：一项开放标签、多中心、单臂、2 期临床试验。

Lancet Oncol. 2021 Jun;22(6):848-857. doi: 10.1016/S1470-2045(21)00126-1. Epub 2021 May 14.

Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.局部晚期基底细胞癌患者停用西米普利单抗后的持久反应。

Clin Exp Dermatol. 2021 Dec;46(8):1612-1614. doi: 10.1111/ced.14804. Epub 2021 Jul 29.

Emerging drugs for the treatment of basal cell carcinoma.新兴的基底细胞癌治疗药物。

Expert Opin Emerg Drugs. 2021 Mar;26(1):17-26. doi: 10.1080/14728214.2021.1873949. Epub 2021 Jan 24.

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.抗 PD-1 单克隆抗体 REGN2810 对转移性基底细胞癌和皮肤鳞状细胞癌的疗效。

J Immunother Cancer. 2016 Nov 15;4:70. doi: 10.1186/s40425-016-0176-3. eCollection 2016.

Anti-PD-1 Therapy Leads to Near-Complete Remission in a Patient with Metastatic Basal Cell Carcinoma.抗 PD-1 治疗导致转移性基底细胞癌患者近乎完全缓解。

Oncol Res Treat. 2018;41(6):391-394. doi: 10.1159/000487084. Epub 2018 May 3.

Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease.在纳武单抗成功治疗难治性转移性疾病期间出现新的皮肤浅表基底细胞癌：对早期与晚期疾病免疫治疗的启示

Int J Mol Sci. 2017 Jul 31;18(8):1663. doi: 10.3390/ijms18081663.

引用本文的文献

Immunotherapy for locally advanced and metastatic basal cell carcinoma: a narrative review.局部晚期和转移性基底细胞癌的免疫治疗：一项叙述性综述。

Transl Cancer Res. 2024 Nov 30;13(11):6565-6575. doi: 10.21037/tcr-24-742. Epub 2024 Nov 6.

Images in Immunotherapy and Precision Oncology: Advanced Basal Cell Carcinoma.免疫治疗与精准肿瘤学中的影像：晚期基底细胞癌

J Immunother Precis Oncol. 2024 Aug 19;7(3):201-204. doi: 10.36401/JIPO-23-47. eCollection 2024 Aug.

Dermatologic Disease-Directed Targeted Therapy (DT): The Application of Biomarker-Based Precision Medicine for the Personalized Treatment of Skin Conditions-Precision Dermatology.皮肤病定向靶向治疗（DT）：基于生物标志物的精准医学在皮肤病个性化治疗中的应用——精准皮肤病学。

Dermatol Ther (Heidelb). 2022 Oct;12(10):2249-2271. doi: 10.1007/s13555-022-00801-2. Epub 2022 Sep 19.

Tattoo-Associated Basal Cell Carcinoma: Coincident or Coincidence.纹身相关的基底细胞癌：并存还是巧合。

Biomed Hub. 2020 Jul 8;5(2):2055-2062. doi: 10.1159/000508208. eCollection 2020 May-Aug.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors.

作者信息

Cohen Philip R, Kurzrock Razelle

机构信息

出版信息

J Am Acad Dermatol. 2020 Jun;82(6):e253-e254. doi: 10.1016/j.jaad.2020.02.052. Epub 2020 Feb 25.

DOI:10.1016/j.jaad.2020.02.052

PMID:32109540

Abstract

摘要

Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Basal cell carcinoma: Management of advanced or metastatic cancer with checkpoint inhibitors and concurrent paradoxical development of new superficial tumors.

作者信息

机构信息

出版信息

相似文献

引用本文的文献